Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay. A 12-month follow-up - Marcucci, R; Gori, AM; Paniccia, R (Circulation, 2009)
et al.